InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Hayes Anthony, Chief Executive Officer. Director active across 1 companies, notably AIkido Pharma Inc.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €16k. The latest transaction was disclosed on 3 May 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€8,20810,000 shares@ €0.820850.0% of flow
Common Stock
SEC:0001213900-21-024405:0·
Ideal exit: 28 Jan 2022 (T+270)
€8,20810,000 shares@ €0.8208100.0% of flow
Common Stock
SEC:0001213900-21-024405·
Ideal exit: 28 Jan 2022 (T+270)
2 of 2 declarations
About Hayes Anthony
Anthony Hayes is the Chief Executive Officer of AIkido Pharma Inc. He is responsible for the strategic direction of the company, overseeing operations and resource management. With a strong background in the pharmaceutical industry, he is committed to promoting innovation and developing treatments that meet patient needs. His leadership is essential for AIkido Pharma's growth and sustainability.
